News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
February 24, 2020
2020

Invetx Announces $15 million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development

News
January 28, 2020
2020

AbCellera is mobilizing a response to the novel coronavirus outbreak as part of its DARPA P3 program

News
October 31, 2019
2019

Dr. Michael Hayden joins AbCellera's Board of Directors

News
September 27, 2019
2019

AbCellera named one of Canada's Top Growing Companies

News
September 5, 2019
2019

AbCellera Appoints Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel

News
June 13, 2019
2019

AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease

News
May 9, 2019
2019

AbCellera Announces Partnership with NIAID Vaccine Research Center and Ichor Medical Systems to Tackle Pandemic Viral Outbreaks

News
March 14, 2019
2019

AbCellera Signs Agreement with Global Health Foundation to Fight Infectious Disease

News
February 28, 2019
2019

AbCellera and Denali Therapeutics Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases

News
February 14, 2019
2019

AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma